Skip to content
10-Q

Quarterly Report

Aquestive Therapeutics, Inc. AQST

0001398733-25-000028

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 122M sh
Shares Diluted Q3 2025 · Sep 30, 2025 110.58M sh
Shares Diluted Q3 2025 · Sep 30, 2025 101.86M sh
Shares Diluted Q3 2025 · Sep 30, 2024 91.08M sh
Shares Diluted Q3 2025 · Sep 30, 2024 85.22M sh
Capex Q3 2025 · Sep 30, 2025 $477K
Capex Q3 2025 · Sep 30, 2024 $144K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$43.96M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$29.27M
Long Term Debt Q3 2025 · Sep 30, 2025 $45M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $129.06M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $71.55M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$4.11M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$72.59M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$60.93M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$60.16M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$45.42M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$35.48M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$36.3M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$106.49M
Current Liabilities Q3 2025 · Sep 30, 2025 $25.57M
Current Liabilities Q3 2025 · Dec 31, 2024 $18.87M
Total Liabilities Q3 2025 · Sep 30, 2025 $167.67M
Total Liabilities Q3 2025 · Dec 31, 2024 $161.58M
Current Assets Q3 2025 · Sep 30, 2025 $151.67M
Current Assets Q3 2025 · Dec 31, 2024 $88.22M
Total Assets Q3 2025 · Sep 30, 2025 $163.56M
Total Assets Q3 2025 · Dec 31, 2024 $101.42M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.14
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.51
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.13
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.32
Eps Basic Q3 2025 · Sep 30, 2025 −$0.14
Eps Basic Q3 2025 · Sep 30, 2025 −$0.51
Eps Basic Q3 2025 · Sep 30, 2024 −$0.13
Eps Basic Q3 2025 · Sep 30, 2024 −$0.32
Sga Expense Q3 2025 · Sep 30, 2025 $15.25M
Sga Expense Q3 2025 · Sep 30, 2025 $47.03M
Sga Expense Q3 2025 · Sep 30, 2024 $12.13M
Sga Expense Q3 2025 · Sep 30, 2024 $34.17M
Rd Expense Q3 2025 · Sep 30, 2025 $4.53M
Rd Expense Q3 2025 · Sep 30, 2025 $14M
Rd Expense Q3 2025 · Sep 30, 2024 $5.27M
Rd Expense Q3 2025 · Sep 30, 2024 $15.36M
Net Income Q3 2025 · Sep 30, 2025 −$15.45M
Net Income Q3 2025 · Sep 30, 2025 −$51.92M
Net Income Q3 2025 · Jun 30, 2025 −$13.55M
Net Income Q3 2025 · Mar 31, 2025 −$22.93M
Net Income Q3 2025 · Sep 30, 2024 −$11.51M
Net Income Q3 2025 · Sep 30, 2024 −$27.08M
Net Income Q3 2025 · Jun 30, 2024 −$2.75M
Net Income Q3 2025 · Mar 31, 2024 −$12.83M
Operating Income Q3 2025 · Sep 30, 2025 −$11.48M
Operating Income Q3 2025 · Sep 30, 2025 −$42.21M
Operating Income Q3 2025 · Sep 30, 2024 −$8.29M
Operating Income Q3 2025 · Sep 30, 2024 −$17.19M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $4.51M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $12.72M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $4.44M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $13.35M
Revenue Q3 2025 · Sep 30, 2025 $12.81M
Revenue Q3 2025 · Sep 30, 2025 $31.53M
Revenue Q3 2025 · Sep 30, 2024 $13.54M
Revenue Q3 2025 · Sep 30, 2024 $45.69M